These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3300230)

  • 1. Sotalol: a beta blocker with unique antiarrhythmic properties.
    Singh BN; Nademanee K
    Am Heart J; 1987 Jul; 114(1 Pt 1):121-39. PubMed ID: 3300230
    [No Abstract]   [Full Text] [Related]  

  • 2. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias.
    Cavusoglu E; Frishman WH
    Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Special symposium: Improvement of Therapy of Cardiac Arrhythmias. Class III Antiarrhythmic Drugs Focussing on Sotalol and D-Sotalol. Nizza, 17-20 June 1992].
    Fortschr Med Suppl; 1992; 135():1-18. PubMed ID: 1358774
    [No Abstract]   [Full Text] [Related]  

  • 4. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.
    Singh BN
    Am J Cardiol; 1993 Aug; 72(4):8A-18A. PubMed ID: 8346731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sotalol in Life-Threatening Ventricular Arrhythmias: A Unique Class III Antiarrhythmic. Symposium proceedings. Phoenix, Arizona, September 19-22, 1991.
    Am J Cardiol; 1993 Aug; 72(4):1A-85A. PubMed ID: 8102220
    [No Abstract]   [Full Text] [Related]  

  • 7. Sotalol: a new agent for the treatment of ventricular arrhythmias.
    Samoil D; Grubb BP; Temesy-Armos PN
    Am J Med Sci; 1994 Jan; 307(1):49-53. PubMed ID: 8291508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is class III antiarrhythmic activity important?
    Singh BN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():597-602. PubMed ID: 2275889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
    Kirschenbaum HL; Rosenberg JM
    Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class III antiarrhythmic action: the way forward?
    Campbell TJ
    Med J Aust; 1993 Jun; 158(11):732-3. PubMed ID: 8341184
    [No Abstract]   [Full Text] [Related]  

  • 11. Class III Antiarrhythmic Drugs: Potential Impact on Arrhythmia Therapy. Symposium proceedings. Nice, France, 17 June 1992.
    Eur Heart J; 1993 Nov; 14 Suppl H():1-99. PubMed ID: 7904933
    [No Abstract]   [Full Text] [Related]  

  • 12. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
    Brachmann J
    Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current application of sotalol in treatment of pediatric cardiac arrhythmia].
    Wu L; He L
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):41-3. PubMed ID: 19573381
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic actions of DL-sotalol in ventricular and supraventricular arrhythmias.
    Singh BN
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S75-90. PubMed ID: 1279313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotalol for cardiac arrhythmias.
    Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of cardiac arrhythmias: The role of encainide and sotalol. A symposium. March 24-25, 1988. Proceedings.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():531-634. PubMed ID: 1980421
    [No Abstract]   [Full Text] [Related]  

  • 18. Promising news about antiarrhythmic drug therapy.
    Check WA
    Am Pharm; 1991 Aug; NS31(8):27-8. PubMed ID: 1927893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiarrhythmic drug effectiveness. Proposal for a new approach based on pharmacological hourly effects].
    Maia IG; Seixas TN; Costa AM; Perez AK; Alves PA
    Arq Bras Cardiol; 1995 Jun; 64(6):525-31. PubMed ID: 8561671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
    Fujiki A
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.